Fennec Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $30.9M | $9.6M | $13.3M |
| FY2024 | $19.3M | $-5.9M | $26.6M |
| FY2025 | — | $35.5M | $36.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | $30.9M | $9.6M | $13.3M |
| FY2024 | $19.3M | $-5.9M | $26.6M |
| FY2025 | — | $35.5M | $36.8M |